Prescribing safety concerns in digital services were highlighted by Talay et al., who identified errors in 4.4% of 37 323 GLP‐1 RA prescriptions (error rate at 44.3 per 1000 prescriptions), predominantly insufficient safety counselling (49.15%) and inadequate contraindication investigations (30.29%),27 in contrast, our study demonstrated substantially lower prescribing error rates at 1.71 per 1000 patients, suggesting that integrated clinical oversight and systematic safety protocols can significantly reduce prescription‐related incidents in digital obesity care. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.